Genexine Inc (095700) — Capital Reinvestment Ratio

Latest as of March 2025: 4.87x

Genexine Inc (095700) has a Capital Reinvestment Ratio of 4.87x as of March 2025, meaning it reinvests 5% of its operating cash flow (₩799.82 Million) in capital expenditures (₩3.89 Billion). See net asset quality index of Genexine Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

4.87x
Capex / Operating Cash Flow

Operating Cash Flow

₩799.82 Million
KRW

Capital Expenditures

₩3.89 Billion
KRW

Data as of

Mar 2025
Most recent filing

Genexine Inc Capital Reinvestment Ratio (2009–2012)

This chart tracks Genexine Inc's Capital Reinvestment Ratio across 2 annual periods. Check how aggressively does Genexine Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Genexine Inc (2009–2012)

Year-by-year Capital Reinvestment Ratio for Genexine Inc from 2009 to 2012. For live market cap and broader valuation context, see Genexine Inc market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2012 1.45x ₩1.67 Billion ₩2.42 Billion ▼ -95.0%
2009 29.24x ₩35.23 Million ₩1.03 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow